Providence inScope Content Team

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.

Noteworthy - September 2024
Read Article
Dr. Walter Urba to retire

Thousands upon thousands of cancer patients and family members at Providence have benefited from the life-changing work of Dr. Walter Urba. Learn about his remarkable career.
Read Article
Gamma Knife upgrade gives Providence Cancer Institute an edge in radiotherapy

The Gamma Knife Esprit stereotactic radiosurgery system moves beyond a fixed headframe to target the most challenging areas of the brain with exceptional accuracy.
Read Article
Noteworthy - Summer 2024
Read Article
Dr. Bernard Fox honored for his lifetime contributions to cancer research

This prestigious award recognizes Dr. Fox’s extraordinary contributions to the field of immunotherapy and his lifelong dedication to advancing cancer research.
Read Article
Expanding access to clinical trials in Hood River: The why and how

What is required to make clinical trials accessible to people in Hood River and other Columbia Gorge communities? Learn more about why it's important to expand access to studies and cancer care.
Read Article
Noteworthy - June 2024
Read Article
Comprehensive care for long COVID patients still remains

Years after the start of the pandemic, more than 200 patients continue to be cared for at Providence for ongoing symptoms that remain from contracting COVID-19. Learn how Providence continues helping.
Read Article
AI-powered digital pathology model advances cancer research and diagnostics

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes.
Read Article
Noteworthy - May 2024
Read Article
Inhibiting an inhibitor: NIH-funded study targets galectin-3 protein

A new investigator-initiated study for patients with metastatic melanoma and HNSCC aims to evaluate a galectin-3 inhibitor as a way to “remove the brakes” from the immune system.
Read Article
Read the report: Providence clinical research innovations
Read Article
Noteworthy - March 2024
Read Article
Looking ahead: Growth and advancements in surgical oncology at Providence Cancer Institute

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.
Read Article
Multiple sclerosis: Using artificial intelligence to expand MRI scan sensitivity

The advent of MRI scanning of the brain and spinal cord was a giant leap forward in improving the ability to diagnose multiple sclerosis with greater sensitivity and reliability.
Read Article
Noteworthy - February 2024
Read Article
Endometrial cancer study aims to improve treatment options

A study led by Dr. Christopher Darus may offer hope to women with persistent endometrial cancer. Currently, the prognosis is poor for women with this form of cancer.
Read Article
Winter Blues and Baby Blues: Can they lead to postpartum depression?

During winter months when the days are shorter and darker, both postpartum depression and baby blues may be more difficult.
Read Article
New pharmacy tool is a resource for treating osteoporosis

The regional pharmacy team regularly updates its Pathway to Treat tool for providers, helping to guide evidence-based care.
Read Article
New guidelines to assess and refer patients for fatty liver disease

Being able to assess the level of fibrosis and make appropriate referrals is important in the care of patients with Steatotic Liver Disease (formerly known as Fatty Liver).
Read Article
Loading More...

Providence inScope Content Team

Noteworthy - September 2024

Dr. Walter Urba to retire

Thousands upon thousands of cancer patients and family members at Providence have benefited from the life-changing work of Dr. Walter Urba. Learn about his remarkable career.

Gamma Knife upgrade gives Providence Cancer Institute an edge in radiotherapy

The Gamma Knife Esprit stereotactic radiosurgery system moves beyond a fixed headframe to target the most challenging areas of the brain with exceptional accuracy.

Noteworthy - Summer 2024

Dr. Bernard Fox honored for his lifetime contributions to cancer research

This prestigious award recognizes Dr. Fox’s extraordinary contributions to the field of immunotherapy and his lifelong dedication to advancing cancer research.

Expanding access to clinical trials in Hood River: The why and how

What is required to make clinical trials accessible to people in Hood River and other Columbia Gorge communities? Learn more about why it's important to expand access to studies and cancer care.

Noteworthy - June 2024

Comprehensive care for long COVID patients still remains

Years after the start of the pandemic, more than 200 patients continue to be cared for at Providence for ongoing symptoms that remain from contracting COVID-19. Learn how Providence continues helping.

AI-powered digital pathology model advances cancer research and diagnostics

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model that will lay the foundation to improve patient outcomes.

Noteworthy - May 2024

Inhibiting an inhibitor: NIH-funded study targets galectin-3 protein

A new investigator-initiated study for patients with metastatic melanoma and HNSCC aims to evaluate a galectin-3 inhibitor as a way to “remove the brakes” from the immune system.

Read the report: Providence clinical research innovations

Noteworthy - March 2024

Looking ahead: Growth and advancements in surgical oncology at Providence Cancer Institute

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

Multiple sclerosis: Using artificial intelligence to expand MRI scan sensitivity

The advent of MRI scanning of the brain and spinal cord was a giant leap forward in improving the ability to diagnose multiple sclerosis with greater sensitivity and reliability.

Noteworthy - February 2024

Endometrial cancer study aims to improve treatment options

A study led by Dr. Christopher Darus may offer hope to women with persistent endometrial cancer. Currently, the prognosis is poor for women with this form of cancer.

Winter Blues and Baby Blues: Can they lead to postpartum depression?

During winter months when the days are shorter and darker, both postpartum depression and baby blues may be more difficult.

New pharmacy tool is a resource for treating osteoporosis

The regional pharmacy team regularly updates its Pathway to Treat tool for providers, helping to guide evidence-based care.

New guidelines to assess and refer patients for fatty liver disease

Being able to assess the level of fibrosis and make appropriate referrals is important in the care of patients with Steatotic Liver Disease (formerly known as Fatty Liver).